Strides Pharma Science Overview
- Year Founded
-
1990
- Status
-
Public
- Employees
-
4,050
- Stock Symbol
-
STAR
- Investments
-
55
- Share Price
-
$10.48
- (As of Thursday Closing)
Strides Pharma Science General Information
Description
Strides Pharma Science Ltd is into the development and manufacture of pharmaceutical products. The company has single segment Pharmaceutical. Pharmaceutical segment represents the business of development, manufacture and Commercialization of pharmaceutical products other than biological drugs. It has presence in North America, Australia, Africa, Europe, and India. The company generates majority of revenue from North America.
Contact Information
Website
www.strides.comCorporate Office
- Strides House
- Bilekahalli, Bannerghatta Road
- Bangalore, 560076
- India
Corporate Office
- Strides House
- Bilekahalli, Bannerghatta Road
- Bangalore, 560076
- India
Strides Pharma Science Stock Performance
As of 19-Nov-2026, Strides Pharma Science’s stock price is $10.48. Its current market cap is $966M with 92.2M shares.
(As of Thursday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $10.48 | $10.25 | $8.35 - $13.13 | $966M | 92.2M | 349K | $0.72 |
Strides Pharma Science Financials Summary
As of 30-Sep-2026, Strides Pharma Science has a trailing 12-month revenue of $562M.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2026 31-Mar-2026 | FY 2025 31-Mar-2025 | FY 2024 31-Mar-2024 |
|---|---|---|---|---|
| EV | 1,240,861 | 1,066,066 | 943,398 | 1,141,125 |
| Revenue | 562,264 | 523,740 | 519,374 | 450,563 |
| EBITDA | 122,211 | 112,482 | 99,488 | 38,021 |
| Net Income | 66,524 | 62,944 | 424,973 | (8,529) |
| Total Assets | 779,669 | 734,186 | 707,128 | 700,265 |
| Total Debt | 198,318 | 186,321 | 219,739 | 301,806 |
Strides Pharma Science Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Strides Pharma Science Comparisons
Industry
Financing
Details
Strides Pharma Science Competitors (39)
One of Strides Pharma Science’s 39 competitors is Glenmark Pharmaceuticals, a Corporation company based in Mumbai, India.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Glenmark Pharmaceuticals | Corporation | Mumbai, India | ||||
| Zydus Lifesciences | Corporation | Ahmedabad, India | ||||
| Beximco Pharmaceuticals | Corporation | Dhaka, Bangladesh | ||||
| Dr. Reddy's | Corporation | Hyderabad, India | ||||
| Alkem Laboratories | Formerly PE-Backed | Mumbai, India |
Strides Pharma Science Patents
Strides Pharma Science Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026120644-A1 | Soft gelatin capsules of acetaminophen and ibuprofen | Pending | 06-Dec-2024 | ||
| AU-2019292334-A1 | Lubrication unit and method of lubricating encapsulated soft gelatin capsule | Active | 26-Jun-2018 | ||
| AU-2019292334-B2 | Lubrication unit and method of lubricating encapsulated soft gelatin capsule | Inactive | 26-Jun-2018 | ||
| US-20210259978-A1 | Lubrication unit and method of lubricating encapsulated soft gelatin capsule | Inactive | 26-Jun-2018 | ||
| WO-2020003326-A1 | Lubrication unit and method of lubricating encapsulated soft gelatin capsule | Inactive | 26-Jun-2018 | A61J3/07 |
Strides Pharma Science Signals
Strides Pharma Science Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Strides Pharma Science Investments & Acquisitions (55)
Strides Pharma Science’s most recent deal was a Corporate Asset Purchase with Sandoz (In-License Multiple Branded Generic Products in South Africa) for . The deal was made on 30-Jun-2026.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Sandoz (In-License Multiple Branded Generic Products in South Africa) | 30-Jun-2026 | Corporate Asset Purchase | Buildings and Property | ||
| LMG Lasers | 26-Jun-2026 | Merger/Acquisition | Surgical Devices | ||
| AMPIN Energy Transition | 31-Dec-2025 | Corporate | Energy Production | ||
| Nostrum Laboratories (Four Approved Abbreviated New Drug Applications ) | 29-Apr-2025 | Corporate Asset Purchase | Buildings and Property | ||
| Amexel | 19-Mar-2025 | Merger/Acquisition | Other Commercial Services |
Strides Pharma Science ESG
Risk Overview
Risk Rating
Updated November, 04, 2026
32.02 | High Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 13,593
Rank
Percentile
Pharmaceuticals
Industry
of 852
Rank
Percentile
Pharmaceuticals
Subindustry
of 354
Rank
Percentile
Strides Pharma Science Exits (11)
Strides Pharma Science’s most recent exit was on 19-Mar-2021 from OneSource Specialty Pharma. The exit was categorized as with 5 buyers.
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| OneSource Specialty Pharma | 19-Mar-2021 | Completed |
|
||
| Pharmapar | 29-Jan-2019 | Completed |
|
||
| Strides Chemicals | 31-Dec-2016 | Completed |
|
||
| Strides Shasun (probiotic business) | 01-Dec-2015 | Completed |
|
||
| Velbiom Probiotics | 25-Nov-2015 | Seed Round | Completed |
|
Strides Pharma Science Affiliates
Subsidiaries (6)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Solara Active Pharma Sciences | Chennai, India | 2017 | |
| Fairmed Healthcare | Zug, Switzerland | 2012 | |
| Vensun Pharmaceuticals | Yardley, PA | 2011 | |
| Trinity Pharma | Sandton, South Africa | 2003 | |
| Beltapharm | Cusano Milanino, Italy | 1982 |
Strides Pharma Science FAQs
-
When was Strides Pharma Science founded?
Strides Pharma Science was founded in 1990.
-
Where is Strides Pharma Science headquartered?
Strides Pharma Science is headquartered in Bangalore, India.
-
What is the size of Strides Pharma Science?
Strides Pharma Science has 4,050 total employees.
-
What industry is Strides Pharma Science in?
Strides Pharma Science’s primary industry is Pharmaceuticals.
-
Is Strides Pharma Science a private or public company?
Strides Pharma Science is a Public company.
-
What is Strides Pharma Science’s stock symbol?
The ticker symbol for Strides Pharma Science is STAR.
-
What is the current stock price of Strides Pharma Science?
As of 19-Nov-2026 the stock price of Strides Pharma Science is $10.48.
-
What is the current market cap of Strides Pharma Science?
The current market capitalization of Strides Pharma Science is $966M.
-
What is Strides Pharma Science’s current revenue?
The trailing twelve month revenue for Strides Pharma Science is $562M.
-
Who are Strides Pharma Science’s competitors?
Glenmark Pharmaceuticals, Zydus Lifesciences, Beximco Pharmaceuticals, Dr. Reddy's, and Alkem Laboratories are some of the 39 competitors of Strides Pharma Science.
-
What is Strides Pharma Science’s annual earnings per share (EPS)?
Strides Pharma Science’s EPS for 12 months was $0.72.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process